Reiff评分对慢性阻塞性肺疾病合并支气管扩张症的临床评估价值
2017-04-01王明明邓毅书
王明明+邓毅书
[摘要] 目前慢性阻塞性肺疾病合并支气管扩张症在中重度慢性阻塞性肺疾病患者中越来越常见,慢性阻塞性肺疾病合并支气管扩张有与慢性阻塞性患者更严重的临床表现,其治疗也有较大异质性,因此借助影像学对慢性阻塞性肺疾病合并支扩患者的评估,将有助于慢阻肺合并支气管扩张症患者的治疗。
[关键词] 慢性阻塞性肺疾病;支气管扩张;Reiff评分
[中图分类号] R563 [文献标识码] A [文章编号] 1674-0742(2017)01(c)-0191-04
Clinical Evaluation Value of Reiff Score on Chronic Obstructive Pulmonary Diseases Combined with Bronchiectasis
WANG Ming-ming1,2, DENG Yi-shu2
1.College of Clinical Medicine, Dali University, Dali, Yunnan Province, 671000 China;2.Department of Respiration, Yunnan Second Peoples Hospital, Kunming, Yunnan Province, 650021 China
[Abstract] Currently, the chronic obstructive pulmonary diseases combined with bronchiectasis is more and more common in patients with severe chronic obstructive pulmonary disease, and the clinical performance of patients with chronic obstructive pulmonary diseases combined with bronchiectasis is more severe than that of patients with chronic obstructive pulmonary diseases, and the treatment is different, therefore, the evaluation of patients with chronic obstructive pulmonary diseases combined with bronchiectasis by imaging will contribute to the treatment of patients with chronic obstructive pulmonary diseases.
[Key wods] Chronic obstructive pulmonary disease; Bronchiectasis; Reiff score
慢性阻塞性肺疾病是全球范圍内最常见的呼吸系统疾病,在发达国家,慢性阻塞性肺疾病是继心血管疾病和癌症后,致死率第3位的疾病,相比较前两种疾病,慢性阻塞性肺疾病的死亡率仍在上升,在未来10年仍会保持上升的趋势[1]。世界卫生组织(WHO)预测在2030年,阻塞性肺疾病将在全球范围内成为致死率第三的疾病[2]慢性阻塞性肺疾病死亡率及患病率的增加给患者及家庭带来了严重的经济负担[3-4]。支气管扩张症是指由支气管粘膜的炎症、感染和修复恶性循环引起的气道直径永久性并且渐进性扩张,并导致粘液纤毛系统的病变继而引起支气管壁破坏[5-7]。
1 慢阻肺合并支扩对患者临床表现的影响
在最近的临床研究中,慢阻肺合并支气管扩张的患者并不少见,已经有研究报道关于中重度慢阻肺患者有更高的支气管扩张的患病率[8-9],在对91例中重度慢阻肺患者的研究中,得出中重度慢阻肺患者更易合并支扩,且多有定植菌存在。……
